OpportunityTitle: Drug Development Tools Research Grants (U01) Clinical Trials Optional
AdditionalInformationOnEligibility: These grants will be used to provide funding to developers of drug development tools that have an accepted or a reviewable Letter of Intent (LOI) within a CDER/CBER&apos;s Drug Development Tool Qualification Program and are working towards their qualification plan (QP) or full qualification package (FQP).If you received DDT research grant support from FDA-CDER/CBER in previous years, you are eligible to apply provided that you have successfully progressed to the next submission milestone (e.g., Accepted LOI to Accepted QP) and are requesting additional funding for new DDT project needs addressing different aspects of the project.
Description: The purpose of this funding opportunity announcement (FOA) is to support research to continue the development of drug development tools that have an accepted or a reviewable Letter of Intent (LOI) within a drug development tool qualification program within either CBER or CDER. The grants will be used to further the development of tools that, once qualified, will be made publicly available to fill unmet needs in drug development.
GrantorContactEmailDescription: terrin.brown@fda.hhs.gov
GrantorContactText: Terrin Brown &lt;br/&gt;Grantor